Kieran McHugh
Overview
Explore the profile of Kieran McHugh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
104
Citations
2557
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Espinoza A, Bagatell R, McHugh K, Naranjo A, Van Ryn C, Rojas Y, et al.
Pediatr Blood Cancer
. 2024 Jul;
71(10):e31218.
PMID: 39072986
Background: Image-defined risk factors (IDRFs) were promulgated for predicting the feasibility and safety of complete primary tumor resection in children with neuroblastoma (NB). There is limited understanding of the impact...
2.
Moreno L, Weston R, Owens C, Valteau-Couanet D, Gambart M, Castel V, et al.
J Clin Oncol
. 2024 Jan;
42(10):1135-1145.
PMID: 38190578
Purpose: Outcomes for children with relapsed and refractory high-risk neuroblastoma (RR-HRNB) remain dismal. The BEACON Neuroblastoma trial (EudraCT 2012-000072-42) evaluated three backbone chemotherapy regimens and the addition of the antiangiogenic...
3.
Ewijk R, Chatziantoniou C, Adams M, Bertolini P, Bisogno G, Bouhamama A, et al.
Pediatr Radiol
. 2023 Sep;
53(12):2539-2551.
PMID: 37682330
Objective: To investigate the feasibility of diffusion-weighted magnetic resonance imaging (DW-MRI) as a predictive imaging marker after neoadjuvant chemotherapy in patients with rhabdomyosarcoma. Material And Methods: We performed a multicenter...
4.
Schoot R, Chisholm J, Casanova M, Minard-Colin V, Geoerger B, Cameron A, et al.
J Clin Oncol
. 2022 Jun;
40(32):3730-3740.
PMID: 35709412
Purpose: Outcome for patients with metastatic rhabdomyosarcoma (RMS) is poor. This study presents the results of the MTS 2008 study with a pooled analysis including patients from the concurrent BERNIE...
5.
Defachelles A, Bogart E, Casanova M, Merks J, Bisogno G, Calareso G, et al.
J Clin Oncol
. 2022 Feb;
40(9):1030-1032.
PMID: 35130027
No abstract available.
6.
Meshaka R, Whittam F, Guessoum M, Eleti S, Shelmerdine S, Arthurs O, et al.
Radiology
. 2021 Dec;
303(1):173-181.
PMID: 34874199
Background Children with pediatric inflammatory syndrome temporally associated with SARS-CoV-2 (PIMS-TS), also known as multisystem inflammatory syndrome in children, present with abdominal pain among other nonspecific symptoms. Although initial imaging...
7.
Defachelles A, Bogart E, Casanova M, Merks J, Bisogno G, Calareso G, et al.
J Clin Oncol
. 2021 Aug;
39(27):2979-2990.
PMID: 34343032
Purpose: The VIT-0910 trial was conducted to evaluate efficacy and safety of the vincristine-irinotecan combination with and without temozolomide (VIT and VI, respectively) in relapsed or refractory rhabdomyosarcoma (RMS). Methods:...
8.
Cameron A, Elze M, Casanova M, Geoerger B, Gaze M, Minard-Colin V, et al.
Int J Radiat Oncol Biol Phys
. 2021 Jul;
111(4):968-978.
PMID: 34217789
Purpose: There is limited evidence to define the role of radiation therapy in children with metastatic rhabdomyosarcoma (mRMS). In the international BERNIE study, children with mRMS or non-RMS soft tissue...
9.
Ewijk R, Schoot R, Sparber-Sauer M, Ter Horst S, Jehanno N, Borgwardt L, et al.
Pediatr Radiol
. 2021 Jun;
51(10):1940-1951.
PMID: 34137936
Appropriate imaging is essential in the treatment of children and adolescents with rhabdomyosarcoma. For adequate stratification and optimal individualised local treatment utilising surgery and radiotherapy, high-quality imaging is crucial. The...
10.
Glosli H, Bisogno G, Kelsey A, Chisholm J, Gaze M, Kolb F, et al.
Eur J Cancer
. 2021 May;
151:84-93.
PMID: 33971448
Background/objectives: The primary aim of this study was to analyse and evaluate the impact of different local treatments on the pattern of relapse in children with primary head and neck...